USA – iCAD, Inc., a leader in AI-powered cancer detection, has announced a strategic collaboration with Microsoft to integrate its ProFound Breast Health Suite into Microsoft’s Precision Imaging Network.
This partnership aims to enhance access to advanced AI-driven mammography solutions across more than 17,000 healthcare facilities nationwide.
The collaboration will see iCAD’s ProFound AI Breast Health Suite fully cloud-hosted on Microsoft’s extensive network, providing radiologists and healthcare providers with streamlined, AI-driven insights to elevate breast health detection, enhance clinical workflows, and ultimately improve patient outcomes.
A key component of this integration is the incorporation of ProFound AI results into Microsoft’s PowerScribe platform, a widely used radiology reporting system in the U.S.
This integration is designed to enable radiologists to efficiently create, review, and share diagnostic reports by leveraging features that standardize language and automate routine tasks.
Dana Brown, CEO and President of iCAD, emphasized the significance of the partnership: “We are excited to partner with Microsoft to expand access to our AI solutions for breast cancer detection across a broader network of healthcare providers.
“This collaboration supports our growth strategy by expanding the reach of our industry-leading technology, driving deeper market penetration, and advancing our transition to a SaaS model.”
The integration comes on the heels of the FDA clearance of iCAD’s ProFound Detection Version 4.0 for Digital Breast Tomosynthesis (DBT).
This latest version utilizes advanced deep learning convolutional neural networks, achieving a 22% improvement in detecting complex and aggressive cancer subtypes over previous versions, with significant enhancements for dense breast tissue.
Additionally, it achieves an 18% reduction in lesion markings, minimizing potential false positives and streamlining radiologists’ workflows.
Microsoft’s Precision Imaging Network serves as a gateway for healthcare providers, offering streamlined access to a curated collection of third-party AI models through a single point of integration.
By embedding iCAD’s capabilities in cancer detection and density assessment, the network delivers targeted, patient-specific insights with unprecedented efficiency.
Vikram Chhabra, General Manager of Diagnostic Solutions at Microsoft, stated, “With the integration of iCAD’s ProFound suite of breast health offerings with our Precision Imaging Network and PowerScribe solutions, we will help provide radiologists and patients with more accurate, actionable breast health insights, while streamlining mammography screening workflow, driving clinical and operational value at scale.”
iCAD will showcase this next-generation AI collaboration, along with its end-to-end breast health AI suite and the recently cleared ProFound Detection Version 4.0, at the upcoming 2025 SIIM25 Annual Meeting + InformaticsTECH Expo in Portland, from May 21st to May 23rd.